BLFS Stock Analysis: Buy, Sell, or Hold?
BLFS - BioLife Solutions Inc.
$37.10
0.13 (0.35%)
▲
5d:
+5.79%
30d:
+20.57%
90d:
+49.96%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 06, 2026
0d
Get Alerted When BLFS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: BLFS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: BLFS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.07
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$9.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLFS is currently trading at $37.10, which is considered extended relative to its 30-day fair value range of $29.68 to $34.61. The stock's valuation (Forward PE: 112.4) is in line with its historical norms (108.1). At these levels, the market is pricing in 1.3% annual earnings growth.
Technical Outlook: Technically, BLFS is in a strong uptrend. The price is approaching resistance at $38.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BLFS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BLFS is in a strong uptrend. The price is approaching resistance at $38.10. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: BLFS scores 15/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $31.29. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$29.68 -
$34.61
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
17.6%
Protect Your Profits
BLFS is technically overbought (RSI 78). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range (+7.2% above its trading range)
- BEARISH: Weak technical setup (15/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 15.7% above Wall St target ($31.29)
- BULLISH: Expecting earnings turnaround to 1.3% growth with 21.5% revenue growth
- WARNING: Composite score 41/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$29.68 -
$34.61
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$33.75
Resistance Level
$38.10
Current Trend
Strong Uptrend
Technical data as of
Aug 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
112.42
Wall Street Target
$31.29
(-15.7%)
Revenue Growth (YoY)
21.5%
Earnings Growth (YoY)
-13.9%
Profit Margin
54.4%
Valuation Premium vs History
+1.3% premium
PE vs Historical
112.4 vs 108.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.3%
(market-implied from PE analysis)
1-Year Target
$37.58
(+1%)
2-Year Target
$38.07
(+3%)
3-Year Target
$38.57
(+4%)
3-Yr Target (if PE normalizes)
(PE: 112→108)
PE COMPRESSION
$37.08
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 112.4, Growth: 32.0%)
$85.33
(+130%)
Base:
(SPY PE: 20.1, Growth: 32.0%)
$15.23
(-59%)
Bear:
(PE: 17.1, Growth: 32.0%)
$12.95
(-65%)
📈
Valuation based on Current Earnings
Trailing PE: 36.97 | Current EPS (TTM): $1.00
Bull Case
$20.33
(-45%)
Analyst growth -50.0%, PE expands to 40.7
Base Case
$18.48
(-50%)
Market implied -50.0%, PE stable at 37.0
Bear Case
$25.14
(-32%)
Severe decline -20.0%, PE contracts to 31.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 23, 2026 2:26 AM ET
Data refreshes hourly during market hours. Next update: 3:26 AM
Data refreshes hourly during market hours. Next update: 3:26 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLFS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Karen A Foster
SELL
500 shares
2026-03-09
Karen A Foster
SELL
96923 shares
2026-03-05
Aby J Mathew
SELL
529 shares
2026-03-03
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$478 | 46 HOLD |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$86 | 37 SELL |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$405 | 66 BUY |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 45 HOLD |
|
RMD
ResMed Inc |
BUY
19 analysts |
$247 | 41 HOLD |
Advanced BLFS Option Strategies
Professional options setups generated by AI based on today's BLFS price and gamma walls.
